CDX2 and lung carcinoma: Pretreatment CDX2 pCTCs can be detected in none of the patients with BCD (colitis, haemorrhoids, colorectal ulcers and hyperplastic polyps) and 2.5% (2 out of 80) patients with other OCC (breast cancer, prostate cancer, liver cancer and lung cancer).